Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

33%(1 trials)

Phase Distribution

Ph phase_4

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 4Post-market surveillance

4(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 44 (100.0%)

Trials by Status

completed375%

withdrawn125%

Recent Activity

0 active trials

Showing 4 of 4

completedphase_4

Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder

NCT00181987

completedphase_4

A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder

NCT00181571

completedphase_4

Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta

NCT00181714

withdrawnphase_4

Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate

NCT00931398

Clinical Trials (4)

Showing 4 of 4 trials

NCT00181987Phase 4

Concerta in the Treatment of ADHD in Youth and Adults With Bipolar Disorder

Completed

NCT00181571Phase 4

A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder

Completed

NCT00181714Phase 4

Prevention of Cigarette Smoking in Attention Deficit Hyperactivity Disorder (ADHD) Youth With Concerta

Completed

NCT00931398Phase 4

Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4